DoseMe Fuels Global Expansion with Appointment of Siegfried Braeuer to Director International Sales

January 31, 2024

DoseMe, a leading provider of precision dosing software for therapeutic drug monitoring (TDM) and creators of DoseMeRx and DoseMe Analytics, today announced the appointment of Siegfried Braeuer to Director, International Sales. In this role, he will lead the expansion of DoseMe’s Model Informed Precision Dosing (MIPD) platform through channel partners and direct sales across multiple continents.

Siegfried Braeuer brings a wealth of experience in pharma with a long tenure at Merck. Additional roles at Swiss Alpinopharma, Amarin GmbH, Interim Management/Consulting and Canpharma, added to Siegfried ‘Sigi’ vast experience building teams across the emerging markets of the Eastern Europe, Middle East, and Africa region. Braeuer, an alumnus of Johannes Kepler University Linz and the MBA program at Emory University, joins DoseMe with more than 20 years of experience leading high-performance teams across pharmaceutical, commercialization and technology spanning multiple geographies including US, UK, Brazil and India.

“The healthcare industry is on a digital transformation journey and EMEA, MEA, Latin America and Asia are fast growing markets with the adoption of precision medicine on an upward trajectory,” said Paul Edwards, CEO of DoseMe. “I am confident that Sigi has the knowledge, skills, proven experience and passion to drive our vision forward and continue to make DoseMe the preferred choice for healthcare organizations.”

In the past year, the company has expanded its distribution network with exclusive resellers across 29 countries. DoseMe continues to focus on product innovation and go-to-market expansion to build new drug models to broaden the MTDM platform. Under Braeuer’s leadership, diversifying the channels and adding new partners will enable the company to offer a wide range of AI-powered systems for real-time patient care.

“DoseMe is at an inflection point as the advent of AI in precision dosing takes shape and is driving the increasing demand around the globe. I am excited to work with these exceptionally talented individuals to achieve our next phase of growth,” said Braeuer.

About DoseMe:
DoseMe combines smart technology with science, leveraging clinically-validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPAA, ISO & FDA compliant and the only Bayesian dosing platform to be HITRUST CSF certified. For more information on successful applications of its products, DoseMeRx and DoseMe Analytics, visit https://doseme-rx.com/success-stories.

Media Contact:
Alison Guzzio
aburnsguzzio@gmail.com
484-459-3243